Flu & Viruses
-
Heart risk after severe COVID
People who have suffered serious illness from COVID face increased risk of ventricular tachycardia, according to a new study. Read more
-
Promising therapy revealed for long COVID fatigue
A potential treatment for fatigue for people with long COVID shows promise after a phase 2 clinical trial, British researchers have reported. Read more
-
Vaccines prevented a million COVID deaths
In just over two years COVID vaccination has saved more than a million lives in Europe, according to a new analysis. Read more
-
Bivalent COVID-19 booster vaccine ‘effective’
The bivalent mRNA COVID-19 vaccine is effective in reducing the risk of hospitalisation or death among older people, according to one of the first studies to assess the vaccine. Read more
-
Long COVID needs single definition, experts say
Long COVID needs a standardised definition to improve diagnosis, treatment and research, experts say. Read more
-
COVID-19 infection ‘increases dementia progression’
Individuals with dementia experience rapidly progressive symptoms after they have had COVID-19, according to a new study. Read more
-
Pandemic safe sexual activity had lasting impact
The reduction in “risky” sexual activity during the early stages of the COVID-19 pandemic continued for a year after Britain’s first lockdown, according to a major new study published today. Read more
-
Severe COVID-19 link to obese patients’ underactive immune response
People with obesity may have increased risk from severe COVID-19 because they have a poorer inflammatory immune response – not because of excessive inflammation in their blood, according to a “surprising” study. Read more
-
Common cold boosts COVID-19 immunity in children
One of the coronaviruses that cause the common cold helps to boost children’s immunity against COVID-19, according to a new Swedish study. Read more
-
Malfunctioning immune cell linked to long COVID
The malfunctioning behaviour of an immune cell could be linked to specific symptoms of long COVID, opening the way to treatments, British researchers have reported. Read more